Gene · 10857
Papers1,901
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,901
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Intriguing Sigma-1 and Sigma-2 Receptors and Their Potential Therapeutic Roles 2.0. | Int J Mol Sci | 2023 | 37958850 | PubTator, text mining | PubMed |
| Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges. | Cancers (Basel) | 2023 | 37958473 | PubTator, text mining | PubMed |
| TOLLIP acts as a cargo adaptor to promote lysosomal degradation of aberrant ER membrane proteins. | EMBO J | 2023 | 37929762 | PubTator, text mining | PubMed |
| Ferroptosis: the emerging player in remodeling triple-negative breast cancer. | Front Immunol | 2023 | 37928550 | PubTator, text mining | PubMed |
| New Insights on the Progesterone (P4) and PGRMC1/NENF Complex Interactions in Colorectal Cancer Progression. | Cancers (Basel) | 2023 | 37894441 | PubTator, text mining | PubMed |
| Developments and Challenges of Miniature Piezoelectric Robots: A Review. | Adv Sci (Weinh) | 2023 | 37888844 | PubTator, text mining | PubMed |
| Progesterone Receptor Membrane Component 1 (PGRMC1) Modulates Tumour Progression, the Immune Microenvironment and the Response to Therapy in Glioblastoma. | Cells | 2023 | 37887342 | PubTator, text mining | PubMed |
| Navigating a plethora of progesterone receptors: Comments on the safety/risk of progesterone supplementation in women with a history of breast cancer or at high-risk for developing breast cancer. | Steroids | 2023 | 37884178 | PubTator, text mining | PubMed |
| The value of metal artifact reduction and iterative algorithms in dual energy CT angiography in patients after complex endovascular aortic aneurysm repair. | Heliyon | 2023 | 37876478 | PubTator, text mining | PubMed |
| Progesterone receptor membrane component 1 facilitates Ca2+ signal amplification between endosomes and the endoplasmic reticulum. | J Biol Chem | 2023 | 37866635 | PubTator, text mining | PubMed |
| Potential Implications of Hyperoside on Oxidative Stress-Induced Human Diseases: A Comprehensive Review. | J Inflamm Res | 2023 | 37854313 | PubTator, text mining | PubMed |
| Identification of transcriptome characteristics of granulosa cells and the possible role of UBE2C in the pathogenesis of premature ovarian insufficiency. | J Ovarian Res | 2023 | 37848988 | PubTator, text mining | PubMed |
| Sigma Receptors: Novel Regulators of Iron/Heme Homeostasis and Ferroptosis. | Int J Mol Sci | 2023 | 37834119 | PubTator, text mining | PubMed |
| Dual mechanism of Let-7i in tumor progression. | Front Oncol | 2023 | 37829341 | PubTator, text mining | PubMed |
| Comprehensive analysis of circRNA expression profile and circRNA-miRNA-mRNA network susceptibility to very early-onset schizophrenia. | Schizophrenia (Heidelb) | 2023 | 37816766 | PubTator, text mining | PubMed |
| Ferroptosis, autophagy, tumor and immunity. | Heliyon | 2023 | 37810047 | PubTator, text mining | PubMed |
| Cell-specific secretory granule sorting mechanisms: the role of MAGEL2 and retromer in hypothalamic regulated secretion. | Front Cell Dev Biol | 2023 | 37799273 | PubTator, text mining | PubMed |
| Chronic kidney outcomes associated with GLP-1 receptor agonists versus long-acting insulins among type 2 diabetes patients requiring intensive glycemic control: a nationwide cohort study. | Cardiovasc Diabetol | 2023 | 37794465 | PubTator, text mining | PubMed |
| Fallopian tube lesions as potential precursors of early ovarian cancer: a comprehensive proteomic analysis. | Cell Death Dis | 2023 | 37775701 | PubTator, text mining | PubMed |
| Uniformly shaped harmonization combines human transcriptomic data from different platforms while retaining their biological properties and differential gene expression patterns. | Front Mol Biosci | 2023 | 37745690 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10857/papers?page=7